Literature DB >> 12392296

Varicella infection following varicella vaccination in a liver transplant recipient.

Josh Levitsky1, Helen S Te, Thomas W Faust, Stanley M Cohen.   

Abstract

Varicella infection may result in significant morbidity and mortality in patients who have received an orthotopic liver transplant (OLT). It is unclear if vaccinating these patients against varicella-zoster virus (VZV) infection is safe or effective. We report on a liver transplant recipient with no prior history of VZV infection who was given the varicella vaccine after an indirect VZV exposure. The patient was subsequently hospitalized twice for treatment of cutaneous varicella infection. We will discuss VZV infection, particularly in relation to liver transplantation, and review the prophylaxis and management of VZV infection after OLT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12392296     DOI: 10.1034/j.1600-6143.2002.20912.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

Review 1.  Aciclovir and varicella-zoster-immunoglobulin in solid-organ transplant recipients.

Authors:  Martina Prelog; Jörn Schönlaub; Lothar Bernd Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2010-11-15       Impact factor: 3.714

2.  Live virus vaccines in transplantation: friend or foe?

Authors:  Charlotte M Verolet; Klara M Posfay-Barbe
Journal:  Curr Infect Dis Rep       Date:  2015-04       Impact factor: 3.725

Review 3.  Live Vaccines in Pediatric Liver Transplant Recipients: "To Give or Not to Give".

Authors:  Sarah Kemme; Taisa J Kohut; Julia M Boster; Tamir Diamond; Elizabeth B Rand; Amy G Feldman
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-10-27

Review 4.  Management of children after renal transplantation: highlights for general pediatricians.

Authors:  Keith K Lau; Lucy Giglia; Howard Chan; Anthony K Chan
Journal:  Transl Pediatr       Date:  2012-07

Review 5.  Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Vaccine       Date:  2012-06-01       Impact factor: 3.641

Review 6.  Efficacy and safety of measles, mumps, rubella and varicella live viral vaccines in transplant recipients receiving immunosuppressive drugs.

Authors:  Angela Marie Danerseau; Joan Louise Robinson
Journal:  World J Pediatr       Date:  2008-12-23       Impact factor: 9.186

7.  Prospective study of live attenuated vaccines for patients receiving immunosuppressive agents.

Authors:  Koichi Kamei; Isao Miyairi; Kenji Ishikura; Masao Ogura; Kensuke Shoji; Katsuhiro Arai; Reiko Ito; Toshinao Kawai; Shuichi Ito
Journal:  PLoS One       Date:  2020-10-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.